Why the study?
It was unknown whether angiotensin II induces apoptosis of human right and left ventricular endocardial endothelial cells and which receptor mediates this effect.
Answers are grounded in this paper and cite their sources.
Angiotensin II induces apoptosis in human ventricular endocardial endothelial cells primarily through the AT2 receptor, which may affect their barrier function and subsequently cardiomyocyte function.
Endocardial endothelial cells (EECs) form a monolayer lining the ventricular cavities. Studies from our laboratory and the literature have shown differences between EECs isolated from the right and left ventricles (EECRs and EECLs, respectively). Angiotensin II (Ang II) was shown to induce apoptosis of different cell types mainly via AT 1 receptor activation. In this study, we verified whether Ang II induces apoptosis of human EECRs and EECLs (hEECRs and hEECLs, respectively) and via which type of receptor. Using the annexin V labeling and in situ TUNEL assays, our results showed that Ang II induced apoptosis of both hEECRs and hEECLs in a concentration-dependent manner. Our results using specific AT 1 and AT 2 receptor antagonists showed that the Ang-II-induced apoptosis in both hEECRs and hEECLs is mediated mainly via the AT 2 receptor. However, AT 1 receptor blockade partially prevented Ang-II-induced apoptosis, particularly in hEECRs. Hence, our results suggest that mainly AT 2 receptors mediate Ang-II-induced apoptosis of hEECRs and hEECLs. The damage of EECs would affect their function as a physical barrier between the blood and cardiomyocytes, thus affecting cardiomyocyte functions.
No takes yet. Share an insight, caveat, or question.
Jacques et al. (2019) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: